FDA label 4e9fdee6-db82-4ea0-8d0d-11b3c9010696

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

SPL set ID
ced48e26-87ad-47a9-b74d-848e100a6644
SPL ID
4e9fdee6-db82-4ea0-8d0d-11b3c9010696
Version
2
Effective date
2018-10-17
Source export date
2026-09-28
Source partition
12
Source file
https://download.open.fda.gov/drug/label/drug-label-0012-of-0014.json.zip
Source object key
raw/openfda/drug-label/2026-09-28/663999d0fe1757c1e2cd13a4799d76d875f663e0bc57701092264ebe7febfc18/drug-label-0012-of-0014.json.zip
Source manifest SHA-256
cd2e66336a5cd2223fa3995098fdbdb84c6a7ee5c0a4addb236ccb22dd1e6887
Import run
20260929T050834Z
Imported at
2026-09-29 06:22:05

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

WARNINGS Severe or persistent sore throat or sore throat accompanied by high fever, headache, nausea, and vomiting may be serious. Consult a health professional promptly. Do not use more than 2 days. This product contains ethanol and should not be inhaled. In rare cases allergicreactions may occur. If pregnant or breast-feeding, ask a health professional before use. Keep out of reach of children . The use of this a by more than one person may spread infection. If symptoms persist or worsen, a health professional should be consulted. Do not use if known sensitivity to ReBoost™ or any of its ingredients exists.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.